Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based ... read more Featured Products: More products

Download Mobile App




Multiplex PCR Panel Evaluated for Diagnosis of Pneumonia

By LabMedica International staff writers
Posted on 28 Jan 2021
Population based studies in the USA estimate the incidence of community-acquired pneumonia at 250 cases per 100,000 residents/year. More...
At any given time, 1% of hospitalized patients receive treatment for hospital-acquired pneumonia, rendering pneumonia the most common healthcare-associated infection.

Despite potential benefits of achieving a microbiological diagnosis of pneumonia, including identifying resistant pathogens and decreasing antimicrobial utilization, a number of factors limit the value of traditional diagnostics in clinical practice. Guidelines emphasize the need for rapid, cost-effective and accurate diagnostic tests for pneumonia.

Infectious Disease Specialists at the New York University Grossman School of Medicine (New York, NY, USA) prospectively examined sputum specimens submitted to the microbiology laboratory for bacterial culture. From 5/2019 to 1/2020, the list of submitted specimens was reviewed twice daily. Expectorated, induced and tracheal aspirate specimens were considered for inclusion. The pneumonia panel was performed on high-quality sputum specimens and the results were prospectively compared with sputum cultures and other tests performed per standard of care.

The BioFire FilmArray Pneumonia Panel (BioFire Diagnostics, Salt Lake City, UT, USA) was run within 24 hours of patient selection. A cutoff of ≥105 copies/mL was applied for semiquantitative bacterial assays. The panel detects semi-quantitatively 15 bacterial agents to assist with differentiation between colonization and true infection, and qualitatively three atypical bacterial and eight viral agents. Antimicrobial resistance genes including the methicillin resistance genes mecA/C and MREJ, the carbapenemases KPC, NDM, Oxa-48-like, VIM, IMP and the extended spectrum Beta-lactamase CTX-M are also detected.

The scientists reported that 70 patients were included, 69 of whom completed a 5-day antimicrobial course for pneumonia and 14.3% died during hospitalization. There was a trend of higher rate of microbiologic diagnosis among the patients with culture submitted before antimicrobial administration (9/15 versus 20/55). The panel increased the microbiologic diagnosis from 29/70 to 59/70 patients. The per isolate analysis revealed an increase in the isolation of Haemophilus influenzae and Streptococcus pneumoniae. On review of empiric antimicrobials, there was potential for antimicrobial optimization in 56/70 patients, including nine bacteria among nine patients, not covered by empiric treatment and another 70 antimicrobials in 49 patients that could have been stopped.

The authors observed a significant increase in the rate of microbiologic diagnosis among adult patients hospitalized with pneumonia where the pneumonia panel was used in addition to current standard of care diagnostic methods, together with abundant opportunities for optimization of antimicrobial therapy. The study was published on January 9, 2021 in the International Journal of Infectious Diseases.

Related Links:
New York University Grossman School of Medicine
BioFire Diagnostics



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.